PubRank

R Knecht

Author PubWeight™ 42.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Amino acid analysis at the picomole level. Application to the C-terminal sequence analysis of polypeptides. Biochem J 1981 1.76
2 Liquid chromatographic determination of amino acids after gas-phase hydrolysis and derivatization with (dimethylamino)azobenzenesulfonyl chloride. Anal Chem 1986 1.52
3 [Tissue microarrays. Value of immunohistochemical proliferation markers for serial investigations of head and neck cancer]. HNO 2004 1.41
4 PLK (polo-like kinase), a new prognostic marker for oropharyngeal carcinomas. Int J Cancer 2000 1.37
5 Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo. Oncogene 2006 1.24
6 Amino acid analysis in the picomole range by precolumn derivatization and high-performance liquid chromatography. Methods Enzymol 1983 1.24
7 Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results. Eur J Radiol 2007 1.07
8 Optimized speech understanding with the continuous interleaved sampling speech coding strategy in patients with cochlear implants: effect of variations in stimulation rate and number of channels. Ann Otol Rhinol Laryngol 2000 1.00
9 A new method for the selective isolation of cysteine-containing peptides. Specific labelling of the thiol group with a hydrophobic chromophore. Biochem J 1983 0.99
10 Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation. Ann Oncol 2010 0.98
11 Sequence determination of eglin C using combined microtechniques of amino acid analysis, peptide isolation, and automatic Edman degradation. Anal Biochem 1983 0.95
12 Results of cochlear implantation in patients with severe to profound hearing loss--implications for patient selection. Audiology 1999 0.95
13 Bazex syndrome (acrokeratosis paraneoplastica). Eur Arch Otorhinolaryngol 1998 0.94
14 The cross-reactive idiotype of anti-4-azobenzenearsonate hybridoma-derived antibodies in A/J mice constitutes multiple heavy chains. Hoppe Seylers Z Physiol Chem 1980 0.93
15 [Infusion therapy in sudden deafness. Reducing the risk of pruritus after hydroxyethyl starch and maintaining therapeutic success--a prospective randomized study]. Laryngorhinootologie 1995 0.92
16 Direct analysis of the disulfide content of proteins: methods for monitoring the stability and refolding process of cystine-containing proteins. Anal Biochem 1991 0.91
17 Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year's literature. Eur Arch Otorhinolaryngol 2012 0.90
18 Primary structure and function of novel O-glycosylated hirudins from the leech Hirudinaria manillensis. Biochemistry 1992 0.87
19 Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2012 0.86
20 Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee. Ann Oncol 2010 0.85
21 Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy. Oral Oncol 2010 0.84
22 Diagnosis of liver cirrhosis with US: receiver-operating characteristic analysis of multidimensional caudate lobe indexes. Radiology 1989 0.84
23 A complete separation of dimethylaminoazobenzenesulphonyl-amino acids. Amino acid analysis with low nanogram amounts of polypeptide with dimethylaminoazobenzenesulphonyl chloride. Biochem J 1982 0.84
24 Canine visceral leishmaniasis caused by Leishmania infantum in Senegal: risk of emergence in humans? Microbes Infect 2010 0.84
25 [Quality assessment according to DIN EN ISO 9001:2000: certification in a university ENT department]. HNO 2006 0.83
26 Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx. Cancer Chemother Pharmacol 2001 0.83
27 Separation, purification, and sequence identification of TGF-beta 1 and TGF-beta 2 from bovine milk. J Protein Chem 1991 0.82
28 Use of representational difference analysis and cDNA arrays for transcriptional profiling of tumor tissue. Ann N Y Acad Sci 2000 0.82
29 Elastase-cathepsin G inhibitors eglin b and eglin c differ by a single Tyr----His substitution. A micro-method for the identification of amino-acid substitution. Biol Chem Hoppe Seyler 1985 0.81
30 Prognostic relevance of volumetric analysis in tumour specimens of hypopharyngeal cancer. Clin Otolaryngol 2007 0.80
31 [Quality management: reduced waiting time and enhanced efficiency in a university ear, nose, and throat outpatient department]. HNO 2007 0.80
32 New treatment strategies for HPV-positive head and neck cancer. Eur Arch Otorhinolaryngol 2013 0.80
33 Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy. Cancer Res 2001 0.80
34 Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up. Eur Arch Otorhinolaryngol 2013 0.80
35 Amino acid sequences of antibody light chain variable regions of pedigreed rabbits: kappa light chain K49-501 (allotype b4 anti-streptococcal group A-variant polysaccharide antibody). Hoppe Seylers Z Physiol Chem 1979 0.80
36 Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness. B-ENT 2006 0.79
37 A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 2015 0.79
38 [New aspects of current therapeutic strategies in oropharyngeal carcinoma: highlights of the 2012 ASCO meeting]. HNO 2012 0.79
39 Purification, characterization and biological evaluation of recombinant leech-derived tryptase inhibitor (rLDTI) expressed at high level in the yeast Saccharomyces cerevisiae. Eur J Biochem 1996 0.79
40 Radiographic examination of patients with dehiscence of semicircular canals with digital volume tomography. Eur Arch Otorhinolaryngol 2012 0.78
41 Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis? Am J Clin Oncol 1997 0.77
42 Current concepts of organ preservation in head and neck cancer. Eur Arch Otorhinolaryngol 2010 0.77
43 A sensitive peptide mapping method. Identification of three amino acid substitutions within two anti-azobenzenearsonate monoclonal antibody light chains. Eur J Biochem 1982 0.77
44 Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients. Clin Otolaryngol 2008 0.77
45 Investigation of noise levels generated by otologic drills. Eur Arch Otorhinolaryngol 2012 0.76
46 Identification of Man alpha1-3Man alpha1-2Man and Man-linked phosphate on O-mannosylated recombinant leech-derived tryptase inhibitor produced by Saccharomyces cerevisiae and determination of the solution conformation of the mannosylated polypeptide. Eur J Biochem 1998 0.76
47 New aspects of induction chemotherapy for head and neck cancer: POSTASCO 2011. Eur Arch Otorhinolaryngol 2012 0.76
48 A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT. Acta Oncol 1993 0.75
49 A follow-up study of long-term results after cochlear implantation in children and adolescents. Eur Arch Otorhinolaryngol 1996 0.75
50 Recombinant hirustasin: production in yeast, crystallization, and interaction with serine proteases. Protein Sci 1997 0.75
51 [The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting]. HNO 2012 0.75
52 [Oncological nonsurgical treatment concepts for head and neck tumors: highlights from the 2012 ASCO annual meeting]. HNO 2012 0.75
53 [Adonco. A clinical-scientific database system for the acquisition and analysis of oncologic data in head and neck regions]. HNO 2005 0.75
54 [Main results of studies on primary therapy of head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014]. HNO 2014 0.75
55 [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area]. Strahlenther Onkol 1995 0.75
56 [Therapy of recurrent and metastatic squamous cell carcinoma of the head and neck : highlights of the ASCO Meeting 2013]. HNO 2013 0.75
57 Imaging of ancient Egyptian mummies' temporal bones with digital volume tomography. Eur Arch Otorhinolaryngol 2012 0.75
58 [Hemorrhage complications in peptic ulcer]. Hospital (Rio J) 1968 0.75
59 [New aspects of primary radiochemotherapy in head and neck cancer. Highlights from the 2011 ASCO Congress]. HNO 2012 0.75
60 [Hereditary sensorineural hearing impairment and macrothrombocytopenia: a rare MYH9 gene mutation]. HNO 2013 0.75
61 [Radiation therapy in head and neck cancer. Highlights from ASCO 2010]. HNO 2010 0.75
62 [New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting]. HNO 2012 0.75
63 [HPV infection in head and neck squamous cell carcinoma (HNSCC). Highlights from ASCO 2010]. HNO 2010 0.75
64 [The most important study results concerning nonsurgical primary treatment of locally advanced head and neck cancer: Highlights of the ASCO Meeting 2015]. HNO 2015 0.75
65 [Immunoglobulin for prevention of radiogenic mucositis]. HNO 1995 0.75
66 [Treatment of head and neck squamous cell carcinoma recurrences and distant metastases: Highlights of the ASCO Meeting 2015]. HNO 2015 0.75
67 Degradation of glomerular basement membrane in diabetes. II. Proteolytic activity of diabetic and nondiabetic glomeruli. Res Exp Med (Berl) 1987 0.75
68 [The most important study results of primary chemoradiation for head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2013]. HNO 2013 0.75
69 [Current status of therapeutic approaches with targeted therapies in malignant thyroid cancer. Highlights from the 2011 ASCO Congress]. HNO 2012 0.75
70 [The current value of induction chemotherapy. ASCO Congress 2010]. HNO 2010 0.75
71 [Anatomo-radiological correlation in cholelithiasis]. Hospital (Rio J) 1965 0.75
72 [Preoperative chemotherapy in head-neck tumors. Chances and risks of this therapeutic procedure]. Laryngorhinootologie 1989 0.75
73 Inventory of economic evaluation of head and neck oncology from the German perspective. Eur Arch Otorhinolaryngol 2014 0.75
74 Trace metals in ancient hair from the Karluk Archaeological Site, Kodiak, Alaska. Int J Circumpolar Health 1999 0.75
75 [Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure]. HNO 1994 0.75
76 [Tumor-associated macrophages (TAM) in the stroma of squamous cell carcinomas of the ENT area studied using monoclonal antibodies]. Laryngorhinootologie 1990 0.75
77 [Transoral robotic total laryngectomy and neck dissection: the concept of robotic combo surgery]. Laryngorhinootologie 2013 0.75
78 Homeless teenagers on New York City streets. Imprint 1991 0.75
79 [New aspects in thyroid cancer treatment: Highlights of the ASCO Annual Meeting 2015]. HNO 2015 0.75
80 [Therapy of recurrent or metastatic head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014]. HNO 2014 0.75
81 [The development of TORS in Europe]. HNO 2013 0.75
82 [Gastic cancer]. Hospital (Rio J) 1968 0.75
83 [Successful coping with declining objective life style by institutionalized long-term patients. Results of a follow-up analysis of quality of life in long-term care institutions with the Zurich Quality of Life Inventory]. Z Gerontol Geriatr 1998 0.75
84 Measurement and comparison of labyrinthine structures with the digital volume tomography: ancient Egyptian mummies' versus today's temporal bones. Eur Arch Otorhinolaryngol 2012 0.75
85 Isolation and purification of novel hirudins from the leech Hirudinaria manillensis by high-performance liquid chromatography. J Chromatogr 1990 0.75
86 [New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress]. HNO 2012 0.75
87 Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT. J Nucl Med 1996 0.75
88 TORS for head and neck squamous cell carcinoma (HNSCC): the Hamburg experience. B-ENT 2015 0.75
89 [Choledocholithiasis]. Hospital (Rio J) 1965 0.75